Cassette mutagenic analysis of the signal peptide of yeast invertase

The SUC2 locus of Saccharomyces cerevisiae encodes two forms of invertase; a constitutively expressed cytoplasmic enzyme and a glucose-repressible secreted and glycosylated enzyme which is initially produced with an amino-terminal signal peptide. The coding sequence of the SUC2 locus has been placed under the control of the constitutive ADH1 promoter and transcription terminator in a centromere based yeast plasmid vector from which invertase is expressed in a Sue" strain of yeast. Oligonucleotide-directed mutagenesis has been used to create a PstI site in the gene at the point encoding the signal peptide cleavage site. An internal methionine codon, the translation start for the cytoplasmic invertase, has been replaced by a serine codon. Mutants in the signal peptide sequence have been produced by replacing the region of the gene upstream of the PstI site with synthetic oligonucleotide cassettes with mixtures of nucleotides at several positions. The mutants could be divided into three classes based on their ability to secrete invertase. The first class of mutants produced secreted invertase, but in reduced amount. There is no obvious correlation between mutation and phenotype. The second class, represented by mutant 4-55B, also exhibited a reduced level of invertase, but a significant fraction (30%) of the enzyme is intracellular. This mutant had a delay in signal peptide cleavage which retards passage of invertase through the secretory pathway. The third class was defective in secretion. Most were defective in translocation from the cytoplasm to the lumen of the endoplasmic reticulum (ER), and produced enzymatically active, non-glycosylated pre-invertase in the cytoplasm. This class of mutant invertases, when transcribed and translated in vitro, was not processed by canine pancreas signal recognition particle (SRP) and microsomes. Comparison of the sequences of the mutant signal peptides of this non-translocating class identifies amino acids at the extreme amino-terminus as the causative defect.Medicine, Faculty ofBiochemistry and Molecular Biology, Department ofGraduat

The effects of morphine on the hypothalamo-neurohypophyseal system

The acute administration of an analgesic dose (1mg/kg) of morphine sulfate to conscious and hydrated rats produced a pronounced antidiuretic response. This was accompanied by an increase in urine osmolality and a decrease in free water clearance in the normal and Brattleboro rats heterozygous for the diabetes insipidus trait. The response was comparable to that of an exogenous dose of vasopressin. Antidiuresis was also observed in the homozygous D.I. rats. Since these rats are incapable of synthesizing vasopressin, the antidiuresis must be mediated by other mechanism(s). When arterial blood pressure was monitored, it was found that the mean arterial pressure decreased sharply immediately after the morphine injection in all animals. This can account for the antidiuresis in the homozygous D.I. rats. In the normal and heterozygous D.I. animals, it is quite possible that both morphine-mediated release of vasopressin and hypotension are responsible for the decrease in urinary flow. In addition, hypotension per se may act as a stimulus for vasopressin release. To study the chronic effects of morphine, rats were rendered tolerant and physically dependent by two means: multiple injections and pellet implantation of morphine sulfate. In contrast to the antidiuretic effects of acute morphine administration, chronic treatment resulted in polyuria. Using a vasopressin radioimmunoassay (RIA), it was found that rats implanted with a morphine pellet for 3 days had a significantly lower neurohypophyseal store of vasopressin (744.3 ± 27.9 ng, n=6) as compared to the placebo pellet implanted controls (1024. 1 ± 66.0 ng, n=6). This depletion was replenished as the animals developed tolerance to the drug.. abrupt withdrawal of the drug from physically dependent animals also produced a significant depletion of the neurohypophyseal vasopressin stores - from 902.4 ± 37.0 ng (n=6) to 638. 3 ± 36.0 ng (n=6). In contrast to rats implanted with morphine pellets, no significant changes in the neurohypophyseal vasopressin stores were observed in those injected daily with morphine for 2 weeks. Withdrawal from the drug in these animals also did not produce any detectable changes in the vasopressin stores. A withdrawal symptom, reduction in body weight, monitored after 24 hr of abstinence suggested that the degree of physical dependence in these animals is very light. ³H-naloxone binding performed on whole brain homogenate of rats injected with morphine for 2 weeks revealed no significant changes in the number of binding sites (q). The affinity constant (Kd) was augmented from a control value of 5.33 nM to 22.37 nM in the morphine-injected rats. The changes in g and Kd suggested the presence of morphine in the whole brain homogenates. Moreover, the Kd was restored to the control value in animals withdrawn from the drug for 24 hr. Vasopressin or oxytocin iid not have any direct effect on the ³H-naloxone binding. Thus, it is unlikely that the facilitation of morphine tolerance by the neurohypophyseal peptides is mediated by their direct action on the opiate receptor.Medicine, Faculty ofCellular and Physiological Sciences, Department ofGraduat